Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher
Pam
P
D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002166:Camptothecin / Q000031:analogs & derivatives / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000453:epidemiology; D016503:Drug Delivery Systems / Q000009:adverse effects / Q000379:methods* / Q000451:nursing; D066246:ErbB Receptors / Q000037:antagonists & inhibitors*; D019317:Evidence-Based Medicine; D005472:Fluorouracil / Q000627:therapeutic use; D006801:Humans; D002955:Leucovorin / Q000627:therapeutic use; D009362:Neoplasm Metastasis / Q000188:drug therapy*; D024802:Nurse's Role; D009859:Oncology Nursing; D009944:Organoplatinum Compounds / Q000627:therapeutic use; D017410:Practice Guidelines as Topic; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*